BRPI1008920A2 - Composição farmacêutica para liberação de compostos inibidores de receptor de tirosina quinase (rtki) para o olho - Google Patents
Composição farmacêutica para liberação de compostos inibidores de receptor de tirosina quinase (rtki) para o olhoInfo
- Publication number
- BRPI1008920A2 BRPI1008920A2 BRPI1008920-9A BRPI1008920A BRPI1008920A2 BR PI1008920 A2 BRPI1008920 A2 BR PI1008920A2 BR PI1008920 A BRPI1008920 A BR PI1008920A BR PI1008920 A2 BRPI1008920 A2 BR PI1008920A2
- Authority
- BR
- Brazil
- Prior art keywords
- rtki
- eye
- release
- pharmaceutical composition
- tyrosine kinase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15698409P | 2009-03-03 | 2009-03-03 | |
PCT/US2010/025998 WO2010101971A1 (en) | 2009-03-03 | 2010-03-03 | Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1008920A2 true BRPI1008920A2 (pt) | 2015-08-25 |
Family
ID=42678477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1008920-9A BRPI1008920A2 (pt) | 2009-03-03 | 2010-03-03 | Composição farmacêutica para liberação de compostos inibidores de receptor de tirosina quinase (rtki) para o olho |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100226992A1 (pt) |
EP (1) | EP2403342A4 (pt) |
JP (1) | JP5583145B2 (pt) |
KR (1) | KR20110123789A (pt) |
CN (2) | CN105362221A (pt) |
AU (1) | AU2010221438C1 (pt) |
BR (1) | BRPI1008920A2 (pt) |
CA (1) | CA2753837A1 (pt) |
MX (1) | MX2011008680A (pt) |
WO (1) | WO2010101971A1 (pt) |
ZA (1) | ZA201105506B (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0710645A2 (pt) | 2006-04-07 | 2012-03-20 | The Procter & Gamble Company | Anticorpos que se ligam à proteína humana tirosina fosfatase beta (hptpbeta) e usos dos mesmos |
US7622593B2 (en) | 2006-06-27 | 2009-11-24 | The Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
TW201023912A (en) | 2008-12-05 | 2010-07-01 | Alcon Res Ltd | Pharmaceutical suspension |
WO2010101989A1 (en) | 2009-03-03 | 2010-09-10 | Alcon Research, Ltd. | PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
RU2519123C2 (ru) | 2009-07-06 | 2014-06-10 | Аэрпио Терапьютикс Инк. | Соединения, композиции и способы предупреждения метастазов раковых клеток |
EP2766043A4 (en) | 2011-10-13 | 2015-06-10 | Aerpio Therapeutics Inc | METHOD FOR THE TREATMENT OF CAPILLARY LECKSYNDROME AND CANCER |
UY34518A (es) * | 2011-12-14 | 2013-07-31 | Abbvie Inc | Composiciones que contienen inhibidores de quinasas |
EP2825166A1 (en) * | 2012-03-12 | 2015-01-21 | Allergan, Inc. | Method of treating ophthalmic conditions with kinase inhibitors |
US20150050277A1 (en) | 2013-03-15 | 2015-02-19 | Aerpio Therapeutics Inc. | Compositions and methods for treating ocular diseases |
MX2016003566A (es) | 2013-09-20 | 2016-06-02 | Santen Pharmaceutical Co Ltd | Composicion que contiene polietilen glicol. |
EP3116503A4 (en) | 2014-03-14 | 2017-08-23 | Aerpio Therapeutics, Inc. | Hptp-beta inhibitors |
WO2016044671A1 (en) * | 2014-09-17 | 2016-03-24 | Panoptica, Inc. | Ocular formulations for drug-delivery and protection of the anterior segment of the eye |
US20180161291A1 (en) * | 2015-06-05 | 2018-06-14 | Kato Pharmaceuticals, Inc. | Extended release urea compositions |
TWI700085B (zh) * | 2015-06-22 | 2020-08-01 | 新源生物科技股份有限公司 | 酪胺酸激酶抑制劑之眼用調配物的用途 |
MX2018003542A (es) | 2015-09-23 | 2018-11-09 | Aerpio Therapeutics Inc | Metodos para tratar presion intraocular con activadores de tie-2. |
CN114269341A (zh) | 2019-04-29 | 2022-04-01 | 视点制药公司 | 靶向施莱姆管的Tie-2激活剂 |
WO2021061687A1 (en) * | 2019-09-27 | 2021-04-01 | Virginia Commonwealth University | Compositions and methods for restoring or increasing tissue perfusion |
CN116251186A (zh) * | 2021-12-09 | 2023-06-13 | 成都瑞沐生物医药科技有限公司 | 一种酪氨酸激酶抑制剂眼用制剂及其制备方法和用途 |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3856919A (en) * | 1970-06-08 | 1974-12-24 | Burton Parsons Chemicals Inc | Ophthalmic solution |
US3931319A (en) * | 1974-10-29 | 1976-01-06 | Millmaster Onyx Corporation | Capped polymers |
US4027020A (en) * | 1974-10-29 | 1977-05-31 | Millmaster Onyx Corporation | Randomly terminated capped polymers |
US4409205A (en) * | 1979-03-05 | 1983-10-11 | Cooper Laboratories, Inc. | Ophthalmic solution |
US4525346A (en) * | 1981-09-28 | 1985-06-25 | Alcon Laboratories, Inc. | Aqueous antimicrobial ophthalmic solutions |
US4407791A (en) * | 1981-09-28 | 1983-10-04 | Alcon Laboratories, Inc. | Ophthalmic solutions |
US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
US4836986A (en) * | 1984-09-28 | 1989-06-06 | Bausch & Lomb Incorporated | Disinfecting and preserving systems and methods of use |
US5002935A (en) * | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
US5037647A (en) * | 1988-09-15 | 1991-08-06 | Alcon Laboratories, Inc. | Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride |
US5461081A (en) * | 1989-09-28 | 1995-10-24 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
US5932572A (en) * | 1992-02-21 | 1999-08-03 | Alcon Laboratories, Inc. | Topical anti-glaucoma compositions |
US5300287A (en) * | 1992-11-04 | 1994-04-05 | Alcon Laboratories, Inc. | Polymeric antimicrobials and their use in pharmaceutical compositions |
ATE189772T1 (de) * | 1993-04-16 | 2000-03-15 | Wakamoto Pharma Co Ltd | Unter wärmeeinwirkung reversibel gelierende medizinische zusammensetzung auf wasserbasis |
CN1126545C (zh) * | 1996-05-07 | 2003-11-05 | 东丽株式会社 | 眼科用制剂 |
NZ334572A (en) * | 1997-07-29 | 1999-08-30 | Alcon Lab Inc | Conditioning solutions for hard contact lens care comprising one or more galactomannans and a borate compound |
WO2001017527A1 (fr) * | 1999-09-06 | 2001-03-15 | Ono Pharmaceutical Co., Ltd. | Agents destines a la prevention et a au traitement des maladies des yeux |
DE60006262T2 (de) * | 1999-09-24 | 2004-05-13 | Alcon, Inc. | Topische suspensionsformulierungen enthaltend ciprofloxacin und dexamethason |
WO2001039765A2 (en) * | 1999-12-03 | 2001-06-07 | Ista Pharmaceuticals, Inc. | Compositions and methods for the induction and treatment of retinal detachments |
EP1282401A2 (en) * | 2000-05-15 | 2003-02-12 | PHARMACIA & UPJOHN S.p.A. | Stabilized steroidal suspension |
WO2002007767A2 (en) * | 2000-07-26 | 2002-01-31 | Alcon Universal Ltd. | Pharmaceutical suspension compositions lacking a polymeric suspending agent |
JP3450805B2 (ja) * | 2000-08-08 | 2003-09-29 | わかもと製薬株式会社 | 水性医薬組成物 |
US20040256749A1 (en) * | 2000-12-22 | 2004-12-23 | Mahesh Chaubal | Process for production of essentially solvent-free small particles |
US6743439B1 (en) * | 2001-06-27 | 2004-06-01 | Alcon, Inc. | Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride |
WO2003026671A1 (en) * | 2001-09-21 | 2003-04-03 | Alcon, Inc. | Method of treating middle ear infections |
US7001615B1 (en) * | 2001-12-07 | 2006-02-21 | Alcon, Inc. | Sustained release ophthalmic, otic and nasal suspension |
US20050025791A1 (en) * | 2002-06-21 | 2005-02-03 | Julius Remenar | Pharmaceutical compositions with improved dissolution |
US20040235892A1 (en) * | 2003-05-22 | 2004-11-25 | Yujia Dai | Indazole and benzisoxazole kinase inhibitors |
SI1638941T1 (sl) * | 2003-05-22 | 2010-11-30 | Abbott Lab | Inhibitorji indazol benzizoksazol in benzizotiazol kinaze |
US20050245497A1 (en) * | 2004-04-08 | 2005-11-03 | Penfold Philip L | Treatment of ophthalmic conditions |
TWI358290B (en) * | 2004-12-02 | 2012-02-21 | Alcon Inc | Topical nepafenac formulations |
TW200640443A (en) * | 2005-02-23 | 2006-12-01 | Alcon Inc | Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors |
PT1885336E (pt) * | 2005-05-10 | 2009-05-07 | Alcon Inc | Formulações de suspensão compreendendo um princípio activo, um tensoactivo poloxâmero ou meroxapol e um glicol, sua utilização no fabrico de um medicamento para tratamento de distúrbios oftálmicos |
DK1906916T3 (da) * | 2005-05-10 | 2009-01-19 | Alcon Inc | Oftalmisk suspension, der omfatter et oftalmisk lægemiddel, en poloxamin og et tonicitetsregulerende glycolbaseret middel, anvendelse af sammensætningen til fremstilling af et medikament til behandling af oftalmiske lidelser |
EP1962803A1 (en) * | 2005-12-23 | 2008-09-03 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
US20070149480A1 (en) * | 2005-12-23 | 2007-06-28 | Alcon, Inc. | PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
US20070173538A1 (en) * | 2005-12-23 | 2007-07-26 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
US20070249546A1 (en) * | 2006-04-22 | 2007-10-25 | Sawaya Assad S | Ophthalmic and related aqueous solutions containing antifungal agents, uses therefor and methods for preparing them |
JP2010534201A (ja) * | 2007-07-20 | 2010-11-04 | アルコン,インコーポレイテッド | 受容体チロシンキナーゼ阻害(RTKi)化合物の目への送達のための医薬製剤 |
TW201023912A (en) * | 2008-12-05 | 2010-07-01 | Alcon Res Ltd | Pharmaceutical suspension |
-
2010
- 2010-03-03 AU AU2010221438A patent/AU2010221438C1/en not_active Ceased
- 2010-03-03 MX MX2011008680A patent/MX2011008680A/es active IP Right Grant
- 2010-03-03 WO PCT/US2010/025998 patent/WO2010101971A1/en active Application Filing
- 2010-03-03 CN CN201510767618.5A patent/CN105362221A/zh active Pending
- 2010-03-03 CN CN2010800101411A patent/CN102340993A/zh active Pending
- 2010-03-03 EP EP10749243.1A patent/EP2403342A4/en not_active Withdrawn
- 2010-03-03 KR KR1020117023002A patent/KR20110123789A/ko not_active Application Discontinuation
- 2010-03-03 JP JP2011553061A patent/JP5583145B2/ja not_active Expired - Fee Related
- 2010-03-03 US US12/716,385 patent/US20100226992A1/en not_active Abandoned
- 2010-03-03 BR BRPI1008920-9A patent/BRPI1008920A2/pt not_active IP Right Cessation
- 2010-03-03 CA CA2753837A patent/CA2753837A1/en not_active Abandoned
-
2011
- 2011-07-26 ZA ZA2011/05506A patent/ZA201105506B/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2011008680A (es) | 2011-09-08 |
AU2010221438C1 (en) | 2015-01-29 |
JP2012519692A (ja) | 2012-08-30 |
JP5583145B2 (ja) | 2014-09-03 |
CA2753837A1 (en) | 2010-09-10 |
CN105362221A (zh) | 2016-03-02 |
KR20110123789A (ko) | 2011-11-15 |
AU2010221438B2 (en) | 2014-10-16 |
EP2403342A1 (en) | 2012-01-11 |
CN102340993A (zh) | 2012-02-01 |
AU2010221438A1 (en) | 2011-08-25 |
EP2403342A4 (en) | 2013-06-05 |
WO2010101971A1 (en) | 2010-09-10 |
US20100226992A1 (en) | 2010-09-09 |
ZA201105506B (en) | 2012-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1008920A2 (pt) | Composição farmacêutica para liberação de compostos inibidores de receptor de tirosina quinase (rtki) para o olho | |
BRPI1012302A2 (pt) | composição farmacêutica para a liberação de compostos de inibição de tirosina quinase receptora (rtki) para o olho | |
DK2345410T3 (da) | Farmaceutisk sammensætning til modificeret frigivelse | |
EP2376495A4 (en) | COMPOSITIONS OF PROTEIN RECEPTOR TYROSINE KINASE INHIBITORS | |
BRPI0911988A2 (pt) | micelas para liberação intracelular de agentes terapêuticos. | |
BRPI0912362A2 (pt) | antagonista do receptor nmda para o tratamento de transtornos neuropsiquiátricos | |
BR112012004525A2 (pt) | composição farmacêuticas gástrico-rententivas para liberação imediata ou prolongada de acetaminofeno | |
BRPI0918971A2 (pt) | tienopirimidinas para composições farmacêuticas | |
EP2341910A4 (en) | DOSAGE FORMS WITH IMMEDIATE RELEASE OF SODIUM OXYBATE | |
DK3354650T3 (da) | Forbindelser der er nyttige som inhibitorer af ATR-kinase | |
BRPI0909780A2 (pt) | Composições e métodos para liberação de fármaco | |
UY33094A (es) | Procedimiento para la preparacion de dronedarona | |
HRP20160744T1 (hr) | Heterocikličke tvari i njihova uporaba kao modulatora receptora tirozin kinaza tipa iii | |
BRPI0913235A2 (pt) | forma de dosagem farmacêutica para liberação imediata de um derivado de indolinona | |
BRPI0916241A2 (pt) | formulações farmacêuticas contendo ligantes de receptores de dopamina | |
BRPI0912428A2 (pt) | formulação farmacêutica sólida de liberação retardada | |
BRPI1011412A2 (pt) | composição para liberação sustentada de droga compreendendo alutinante geopolimérico | |
CL2014002986A1 (es) | Proceso para la preparacion de compuestos derivados de 2-(1-hidroxi-alquil)-cromen-4-ona opticamente puros y opcionalmente sustituidos; compuestos derivados de 2-(1-hidroxi-alquil)-cromen-4-ona; composicion farmaceutica que los comprende; y su uso para preparar compuestos inhibidores de pi3k. | |
BRPI0909270A2 (pt) | Compostos de sirna para inibição de rtp801 | |
EA201101118A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина | |
TN2009000510A1 (en) | Extended release formulation of nevirapine | |
DK2462098T3 (da) | Fremgangsmåde til fremstillingen af derivater af 1-(2-halobiphenyl-4-yl)-cyclopropancarboxylsyre | |
BRPI0812250A2 (pt) | Composição farmacêutica de liberação lenta feita de micropartículas | |
AU2007356856A1 (en) | Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (RTKI) compounds to the eye | |
BRPI0923003A2 (pt) | composição de liberação controlada para produção de uma preparação de liberação prolongada contendo udenafil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |